Polyploid cell dynamics and death before and after PEG-treatment of a NIH/3T3 derived culture: vinblastine effects on the regulation of cell subpopulations heterogeneity.
Autophagic-like death
Cell fusion
Mitotic anomalies
Polyploidy
Journal
Cell division
ISSN: 1747-1028
Titre abrégé: Cell Div
Pays: England
ID NLM: 101251560
Informations de publication
Date de publication:
30 Oct 2023
30 Oct 2023
Historique:
received:
26
07
2023
accepted:
14
10
2023
medline:
31
10
2023
pubmed:
31
10
2023
entrez:
31
10
2023
Statut:
epublish
Résumé
Neoplastic subpopulations can include polyploid cells that can be involved in tumor evolution and recurrence. Their origin can be traced back to the tumor microenvironment or chemotherapeutic treatment, which can alter cell division or favor cell fusion, generating multinucleated cells. Their progeny, frequently genetically unstable, can result in new aggressive and more resistant to chemotherapy subpopulations. In our work, we used NIHs cells, previously derived from the NIH/3T3 line after serum deprivation, that induced a polyploidization increase with the appearance of cells with DNA content ranging from 4 to 24c. This study aimed to analyze the cellular dynamics of NIHs culture subpopulations before and after treatment with the fusogenic agent polyethylene glycol (PEG), which allowed us to obtain new giant polyploid cells. Successively, PEG-untreated and PEG-treated cultures were incubated with the antimicrotubular poison vinblastine. The dynamics of appearance, decrease and loss of cell subpopulations were evaluated by correlating cell DNA content to mono-multinuclearity resulting from cell fusion and division process alteration and to the peculiarities of cell death events. DNA microfluorimetry and morphological techniques (phase contrast, fluorescence and TEM microscopies) indicated that PEG treatment induced a 4-24c cell increase and the appearance of new giant elements (64-140c DNA content). Ultrastructural analysis and autophagosomal-lysosomal compartment fluorochromization, which allowed us to correlate cytoplasmic changes to death events, indicated that cell depletion occurred through distinct mechanisms: apoptotic death involved 2c, 4c and 8c cells, while autophagic-like death involved intermediate 12-24c cells, showing nuclear (lobulation/micronucleation) and autophagic cytoplasm alterations. Death, spontaneously occurring, especially in intermediate-sized cells, was increased after vinblastine treatment. No evident cell loss by death events was detected in the 64-140c range. PEG-treated NIHs cultures can represent a model of heterogeneous subpopulations originating from cell fusion and division process anomalies. Altogether, our results suggest that the different cell dynamics of NIHs subpopulations can affect the variability of responses to stimuli able to induce cell degeneration and death. Apoptptic, autophagic or hybrid forms of cell death can also depend on the DNA content and ability to progress through the cell cycle, which may influence the persistence and fate of polyploid cell descendants, also concerning chemotherapeutic agent action.
Sections du résumé
BACKGROUND
BACKGROUND
Neoplastic subpopulations can include polyploid cells that can be involved in tumor evolution and recurrence. Their origin can be traced back to the tumor microenvironment or chemotherapeutic treatment, which can alter cell division or favor cell fusion, generating multinucleated cells. Their progeny, frequently genetically unstable, can result in new aggressive and more resistant to chemotherapy subpopulations. In our work, we used NIHs cells, previously derived from the NIH/3T3 line after serum deprivation, that induced a polyploidization increase with the appearance of cells with DNA content ranging from 4 to 24c. This study aimed to analyze the cellular dynamics of NIHs culture subpopulations before and after treatment with the fusogenic agent polyethylene glycol (PEG), which allowed us to obtain new giant polyploid cells. Successively, PEG-untreated and PEG-treated cultures were incubated with the antimicrotubular poison vinblastine. The dynamics of appearance, decrease and loss of cell subpopulations were evaluated by correlating cell DNA content to mono-multinuclearity resulting from cell fusion and division process alteration and to the peculiarities of cell death events.
RESULTS
RESULTS
DNA microfluorimetry and morphological techniques (phase contrast, fluorescence and TEM microscopies) indicated that PEG treatment induced a 4-24c cell increase and the appearance of new giant elements (64-140c DNA content). Ultrastructural analysis and autophagosomal-lysosomal compartment fluorochromization, which allowed us to correlate cytoplasmic changes to death events, indicated that cell depletion occurred through distinct mechanisms: apoptotic death involved 2c, 4c and 8c cells, while autophagic-like death involved intermediate 12-24c cells, showing nuclear (lobulation/micronucleation) and autophagic cytoplasm alterations. Death, spontaneously occurring, especially in intermediate-sized cells, was increased after vinblastine treatment. No evident cell loss by death events was detected in the 64-140c range.
CONCLUSIONS
CONCLUSIONS
PEG-treated NIHs cultures can represent a model of heterogeneous subpopulations originating from cell fusion and division process anomalies. Altogether, our results suggest that the different cell dynamics of NIHs subpopulations can affect the variability of responses to stimuli able to induce cell degeneration and death. Apoptptic, autophagic or hybrid forms of cell death can also depend on the DNA content and ability to progress through the cell cycle, which may influence the persistence and fate of polyploid cell descendants, also concerning chemotherapeutic agent action.
Identifiants
pubmed: 37904245
doi: 10.1186/s13008-023-00100-y
pii: 10.1186/s13008-023-00100-y
pmc: PMC10614354
doi:
Types de publication
Journal Article
Langues
eng
Pagination
18Subventions
Organisme : Università degli Studi di Sassari
ID : Fondo di Ateneo per la ricerca 2020
Organisme : Università degli Studi di Sassari
ID : Fondo di Ateneo per la ricerca 2020
Informations de copyright
© 2023. The Author(s).
Références
Exp Cell Res. 2010 Aug 1;316(13):2099-112
pubmed: 20457152
Cell Stem Cell. 2019 Jan 3;24(1):41-53
pubmed: 30609398
Cancers (Basel). 2020 Feb 13;12(2):
pubmed: 32069980
Genes Dev. 2009 Nov 1;23(21):2461-77
pubmed: 19884253
Drug Resist Updat. 2016 Jan;24:1-12
pubmed: 26830311
BMC Cell Biol. 2004 Sep 29;5(1):35
pubmed: 15456512
Curr Opin Genet Dev. 2007 Apr;17(2):157-62
pubmed: 17324569
J Immunol Methods. 1985 Aug 2;81(2):223-8
pubmed: 4020150
In Vitro Cell Dev Biol Anim. 2006 Jul-Aug;42(7):216-24
pubmed: 16948503
Cell Death Differ. 2019 Mar;26(4):605-616
pubmed: 30568239
FEBS J. 2015 May;282(10):1858-70
pubmed: 25735653
Apoptosis. 2006 Mar;11(3):367-75
pubmed: 16538380
Front Cell Dev Biol. 2017 Mar 31;5:30
pubmed: 28409150
Front Oncol. 2014 May 26;4:123
pubmed: 24904834
Eur Biophys J. 2007 Apr;36(4-5):315-26
pubmed: 17039359
Arch Pathol Lab Med. 1994 Sep;118(9):912-6
pubmed: 8080361
Cold Spring Harb Protoc. 2018 Mar 1;2018(3):
pubmed: 29496822
BMC Cell Biol. 2004 Aug 19;5:30
pubmed: 15317658
Cell. 2007 Nov 2;131(3):437-40
pubmed: 17981108
Cell Biol Int. 2000;24(9):621-33
pubmed: 10964452
Cell Cycle. 2012 Aug 1;11(15):2864-75
pubmed: 22801546
Cancer Cell Int. 2011 Sep 20;11:32
pubmed: 21933375
Oncogene. 2004 Apr 12;23(16):2825-37
pubmed: 15077146
Nutr Cancer. 2021;73(1):147-159
pubmed: 31690139
Molecules. 2016 Jul 12;21(7):
pubmed: 27420038
Trends Genet. 2008 Sep;24(9):457-66
pubmed: 18675487
Mutat Res Rev Mutat Res. 2017 Jan - Mar;771:85-98
pubmed: 28342454
Cell Oncol. 2006;28(4):177-90
pubmed: 16988473
Methods Mol Biol. 2006;325:59-66
pubmed: 16761719
Antioxidants (Basel). 2022 Jan 05;11(1):
pubmed: 35052621
Hybridoma. 1988 Dec;7(6):627-33
pubmed: 3235098
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
Biosci Biotechnol Biochem. 2018 Mar 2;:1-6
pubmed: 29499630
J Cell Sci. 2016 Dec 15;129(24):4622-4632
pubmed: 27875278
Cancers (Basel). 2018 Apr 15;10(4):
pubmed: 29662021
J Biol Chem. 2003 Apr 11;278(15):13520-30
pubmed: 12574163
Histol Histopathol. 2008 Jun;23(6):717-30
pubmed: 18366010
Cell Biol Int. 2011 Jul;35(7):687-95
pubmed: 21250945
J Immunol Methods. 1978;19(2-3):169-72
pubmed: 624839
Biochim Biophys Acta Mol Cell Res. 2019 Mar;1866(3):409-417
pubmed: 30315834
Mol Biol Cell. 2004 Nov;15(11):4938-48
pubmed: 15331766
Cancer Biol Ther. 2004 Feb;3(2):207-18
pubmed: 14726689
Somatic Cell Genet. 1976 Mar;2(2):165-76
pubmed: 1028164
Bioessays. 2017 Sep;39(9):
pubmed: 28752618
Biophys J. 2007 Aug 1;93(3):969-80
pubmed: 17416619
Nat Rev Mol Cell Biol. 2011 Jun;12(6):385-92
pubmed: 21527953
Virchows Arch. 2001 Dec;439(6):768-75
pubmed: 11787849
Cell Biol Int. 2005 Dec;29(12):1012-8
pubmed: 16310380
Biol Res. 2010;43(2):205-24
pubmed: 21031266
Methods Cell Biol. 1990;33:285-98
pubmed: 1707487
Oncogene. 2014 Jan 2;33(1):116-28
pubmed: 23524583
Cell Cycle. 2014;13(1):138-47
pubmed: 24196447
Cancer Res. 2007 Feb 1;67(3):1030-7
pubmed: 17283135
Nat Rev Mol Cell Biol. 2004 Jan;5(1):45-54
pubmed: 14708009